Active	Status	Sponsor type	Region	Phase	Filter
8 Active 2 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hale, Daniel E
OraGrowtH210, NCT04614337 / 2020-000874-92: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency ( Trial)	Completed	2	82	Europe, US, RoW	LUM-201, rhGH Norditropin® pen (34 µg/kg)	Lumos Pharma, Lumos Pharma	Growth Hormone Deficiency	09/24	09/24
Cody, Janinne
No trials found
Meyer, Andrew
No trials found
Foster, Megan
No trials found
Gelfond, Jonathan
No trials found